Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,141 | 59 | 65.3% |
| Travel and Lodging | $1,139 | 3 | 34.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $2,295 | 13 | $0 (2019) |
| Novo Nordisk Inc | $196.40 | 12 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $173.13 | 5 | $0 (2020) |
| Xeris Pharmaceuticals, Inc. | $70.72 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $55.34 | 3 | $0 (2023) |
| Lilly USA, LLC | $53.75 | 3 | $0 (2024) |
| ABBVIE INC. | $48.12 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $47.86 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $42.67 | 2 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.84 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $209.22 | 11 | GlaxoSmithKline, LLC. ($47.86) |
| 2023 | $225.73 | 12 | Novo Nordisk Inc ($67.30) |
| 2022 | $288.02 | 16 | ABBVIE INC. ($48.12) |
| 2021 | $70.46 | 4 | Novo Nordisk Inc ($70.46) |
| 2020 | $16.52 | 1 | Zimmer Biomet Holdings, Inc. ($16.52) |
| 2019 | $2,320 | 14 | Medtronic USA, Inc. ($2,285) |
| 2018 | $33.39 | 2 | Zimmer Biomet Holdings, Inc. ($22.79) |
| 2017 | $116.68 | 2 | Zimmer Biomet Holdings, Inc. ($116.68) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.96 | General |
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes Care | ||||||
| 07/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 06/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Obesity | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: RESPIRATORY | ||||||
| 01/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: VACCINE | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Gastroenterology | ||||||
| 11/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes Care | ||||||
| 10/30/2023 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE, NEXLETOL | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neurology | ||||||
| 09/25/2023 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 09/18/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Diabetes | ||||||
| 08/09/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Gastroenterology | ||||||
| 05/17/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Obesity | ||||||
| 04/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 02/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardio-renal | ||||||
| 01/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Obesity | ||||||
| 01/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.25 | General |
| 11/28/2022 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Rare Disease | ||||||
| 11/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 351 | 540 | $259,185 | $77,194 |
| 2022 | 11 | 401 | 543 | $376,390 | $112,979 |
| 2021 | 8 | 347 | 472 | $168,930 | $53,021 |
| 2020 | 8 | 343 | 458 | $172,835 | $45,237 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 22633 | Fusion of spine in lower back with partial removal of spine bone and disc | Facility | 2023 | 15 | 15 | $71,100 | $21,158 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $29,140 | $11,165 | 38.3% |
| 22634 | Fusion of additional segment of spine with partial removal of spine bone and disc | Facility | 2023 | 13 | 29 | $37,120 | $10,963 | 29.5% |
| 22853 | Insertion of cage or mesh device to spine bone and disc space during spine fusion | Facility | 2023 | 15 | 45 | $30,150 | $9,057 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 116 | $18,560 | $6,755 | 36.4% |
| 63053 | Partial removal of bone of additional segment of spine in lower back with release of spinal cord and/or nerves during fusion of spine in lower back | Facility | 2023 | 12 | 31 | $15,190 | $5,532 | 36.4% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 60 | 121 | $23,180 | $3,182 | 13.7% |
| 63052 | Partial removal of bone of single segment of spine in lower back with release of spinal cord and/or nerves during fusion of spine in lower back | Facility | 2023 | 15 | 15 | $9,825 | $3,023 | 30.8% |
| 61783 | Computer-assisted spinal procedure | Facility | 2023 | 16 | 16 | $12,800 | $2,904 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 30 | $7,200 | $2,701 | 37.5% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 16 | 28 | $4,920 | $753.25 | 15.3% |
| 22633 | Fusion of spine in lower back with partial removal of spine bone and disc | Facility | 2022 | 24 | 24 | $113,760 | $34,652 | 30.5% |
| 22634 | Fusion of additional segment of spine with partial removal of spine bone and disc | Facility | 2022 | 21 | 40 | $51,200 | $15,854 | 31.0% |
| 22853 | Insertion of cage or mesh device to spine bone and disc space during spine fusion | Facility | 2022 | 25 | 64 | $42,880 | $13,186 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 106 | 106 | $32,860 | $13,073 | 39.8% |
| 22842 | Placement of stabilizing device to back, 3-6 spine bone segments | Facility | 2022 | 17 | 17 | $33,490 | $10,355 | 30.9% |
| 63047 | Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | Facility | 2022 | 12 | 12 | $33,600 | $7,057 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 68 | $16,320 | $5,659 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 76 | $12,160 | $4,703 | 38.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 58 | 108 | $19,460 | $2,994 | 15.4% |
| 61783 | Computer-assisted spinal procedure | Facility | 2022 | 16 | 16 | $12,800 | $2,985 | 23.3% |
| 63052 | Partial removal of bone of single segment of spine in lower back with release of spinal cord and/or nerves during fusion of spine in lower back | Facility | 2022 | 12 | 12 | $7,860 | $2,461 | 31.3% |
| 22633 | Fusion of lower spine bones with removal of disc, posterior or posterolateral approach, single interspace and segment | Facility | 2021 | 14 | 14 | $77,540 | $20,988 | 27.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 133 | $17,115 | $8,049 | 47.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $13,480 | $6,446 | 47.8% |
About Dr. Michael Eppig, MD
Dr. Michael Eppig, MD is a Orthopaedic Surgery healthcare provider based in Concord Twp, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073536611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Eppig, MD has received a total of $3,280 in payments from pharmaceutical and medical device companies, with $209.22 received in 2024. These payments were reported across 62 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,141).
As a Medicare-enrolled provider, Eppig has provided services to 1,442 Medicare beneficiaries, totaling 2,013 services with total Medicare billing of $288,431. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Concord Twp, OH
- Active Since 07/25/2006
- Last Updated 01/31/2019
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1073536611
Products in Payments
- CD HORIZON (Device) $2,267
- ROI-C (Device) $105.18
- Wegovy (Drug) $75.43
- Biomet SpinalPak (Device) $56.45
- XIFAXAN (Drug) $55.34
- KEVEYIS (Drug) $48.15
- VRAYLAR (Drug) $48.12
- TRELEGY ELLIPTA (Drug) $47.86
- Kerendia (Drug) $42.67
- NURTEC ODT (Drug) $39.84
- FREESTYLE LIBRE 3 (Device) $39.66
- JARDIANCE (Drug) $38.92
- EVENITY (Biological) $27.44
- GVOKE HYPOPEN (Drug) $22.57
- Xofluza (Drug) $20.82
- GARDASIL (Biological) $20.73
- STRENSIQ (Biological) $20.10
- AIRSUPRA (Drug) $20.00
- Tirosint (Drug) $19.65
- PICO 7 Single Use Negative Pressure Wound Therapy (Device) $18.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.